Your browser doesn't support javascript.
loading
RANKL/RANK control Brca1 mutation- .
Sigl, Verena; Owusu-Boaitey, Kwadwo; Joshi, Purna A; Kavirayani, Anoop; Wirnsberger, Gerald; Novatchkova, Maria; Kozieradzki, Ivona; Schramek, Daniel; Edokobi, Nnamdi; Hersl, Jerome; Sampson, Aishia; Odai-Afotey, Ashley; Lazaro, Conxi; Gonzalez-Suarez, Eva; Pujana, Miguel A; Cimba, For; Heyn, Holger; Vidal, Enrique; Cruickshank, Jennifer; Berman, Hal; Sarao, Renu; Ticevic, Melita; Uribesalgo, Iris; Tortola, Luigi; Rao, Shuan; Tan, Yen; Pfeiler, Georg; Lee, Eva Yhp; Bago-Horvath, Zsuzsanna; Kenner, Lukas; Popper, Helmuth; Singer, Christian; Khokha, Rama; Jones, Laundette P; Penninger, Josef M.
Afiliação
  • Sigl V; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Owusu-Boaitey K; Department of Biological Sciences, University of Maryland-Baltimore County, Baltimore, MD 21250, USA.
  • Joshi PA; Princess Margaret Cancer Centre, Toronto, Ontario, Canada M5G 1L7.
  • Kavirayani A; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Wirnsberger G; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Novatchkova M; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Kozieradzki I; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Schramek D; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5.
  • Edokobi N; Department of Molecular Genetics, University of Toronto, Ontario, Canada M5S 3E1.
  • Hersl J; Department of Biological Sciences, University of Maryland-Baltimore County, Baltimore, MD 21250, USA.
  • Sampson A; Department of Pharmacology, University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201, USA.
  • Odai-Afotey A; Department of Pharmacology, University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201, USA.
  • Lazaro C; Department of Biological Sciences, Cornell University, Ithaca, NY 14853, USA.
  • Gonzalez-Suarez E; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Pujana MA; Cancer Epigenetics and Biology Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Cimba F; ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Heyn H; Department of Public and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Vidal E; Cancer Epigenetics and Biology Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Cruickshank J; Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, University Pompeu Fabra, Barcelona, Catalonia, Spain.
  • Berman H; The Campbell Family Institute for Breast Cancer Research, University Health Network, Toronto, Ontario, Canada M5G 1Z5.
  • Sarao R; The Campbell Family Institute for Breast Cancer Research, University Health Network, Toronto, Ontario, Canada M5G 1Z5.
  • Ticevic M; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Uribesalgo I; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Tortola L; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Rao S; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Tan Y; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna 1030, Austria.
  • Pfeiler G; Departments of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria.
  • Lee EY; Departments of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria.
  • Bago-Horvath Z; Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA 92697, USA.
  • Kenner L; Department of Experimental Pathology and Pathology of Laboratory Animals, Medical University Vienna and University of Veterinary Medicine Vienna, Vienna 1090, Austria.
  • Popper H; Department of Experimental Pathology and Pathology of Laboratory Animals, Medical University Vienna and University of Veterinary Medicine Vienna, Vienna 1090, Austria.
  • Singer C; Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.
  • Khokha R; Research Unit Molecular Lung and Pleura Pathology, Institute of Pathology, Medical University Graz, Graz 8010, Austria.
  • Jones LP; Departments of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria.
  • Penninger JM; Princess Margaret Cancer Centre, Toronto, Ontario, Canada M5G 1L7.
Cell Res ; 26(7): 761-74, 2016 07.
Article em En | MEDLINE | ID: mdl-27241552
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína BRCA1 / Ligante RANK / Receptor Ativador de Fator Nuclear kappa-B Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína BRCA1 / Ligante RANK / Receptor Ativador de Fator Nuclear kappa-B Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article